Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 138 M131 M143 M169 M137 M139 M 588 M Research & development —————— — Operating income 399 M304 M400 M187 M447 M348 M 1.38 B Non-Operating Income, Total 3 M-18 M-10 M1 M-11 M6 M -14 M Interest expense, net of interest capitalized 1 M01 M01 M0 2 M Non-Operating Income, excl. Interest Expenses 2 M-18 M-11 M1 M-12 M6 M -16 M Unusual income/expense —————— — Pretax income 428 M311 M413 M206 M452 M354 M 1.43 B Equity in earnings 4 M2 M6 M3 M2 M2 M 13 M Taxes 119 M80 M114 M56 M123 M92 M 385 M Non-controlling/minority interest 21 M18 M23 M13 M22 M20 M 78 M After tax other income/expense —————— — Net income before discontinued operations 292 M215 M282 M140 M309 M244 M 975 M Discontinued operations —————— — Net income 292 M215 M282 M140 M309 M244 M 975 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 292 M215 M282 M140 M309 M244 M 975 M Basic earnings per share (Basic EPS) 0.780.580.760.40.880.7 2.74 Diluted earnings per share (Diluted EPS) 0.770.580.760.40.870.7 2.73 Average basic shares outstanding 376 M373 M368 M369 M353 M348 M — Diluted shares outstanding 378 M374 M369 M371 M354 M349 M — EBITDA 508 M414 M514 M302 M564 M468 M 1.85 B EBIT 399 M304 M400 M187 M447 M348 M 1.38 B Cost of revenue 2.28 B2.19 B2.48 B2.29 B2.49 B2.44 B 9.7 B Other cost of goods sold 2.28 B2.19 B2.48 B2.29 B2.49 B2.44 B 9.7 B Depreciation & amortization (cash flow) 109 M110 M114 M115 M117 M120 M 466 M